Biolab Farmacêutica, Genéricos and Avert Saúde Humana present novelties during Conexão Farma 2026
With a focus on strengthening the pharmaceutical chain, brands bring solutions to boost the point of sale
Biolab & Co. is taking part in Abradilan's Conexão Farma 2026, with a focus on strengthening partnerships with retailers and distributors, bringing its Biolab Farmacêutica, Genéricos and Avert Saúde Humana brands. This year's highlight is the activation of the latest launch of the Avert® Saúde Humana range: Smurfs Vitamins. The novelty combines health care and a playful approach for the children's supplementation segment, with strong commercial appeal. At the more than 150m² stand, the characters will be present to promote the range.
The company also highlights its Generics line as a strategic choice for retailers, combining high reliability and democratization of access to healthcare. “Our strategy is to offer points of sale products that follow a rigorous standard of quality and technology in all our brands. In this way, we strengthen the growth of our partners and ensure that the end of the chain has access to the most advanced products in the sector,” says Tati Marques, Director of Communication, Education and Sustainability at Biolab & Co.
Smurfs Vitamins
The children's supplement line was developed to combine health and practicality in families' daily lives and has two presentations:
Liquid Oral Solution (120ml): With an orange flavor, it contains 10 essential vitamins (A, C, D, E and B complex). Its composition aids energy metabolism, the maintenance of calcium levels and the formation of red blood cells.
Gummies (30 pieces): They come in grape (Vitamin C + Zinc) and strawberry (Multivitamin A to Z) flavors. The highlight is the presence of Zinc, a mineral and antioxidant that helps the immune system function, synthesizes proteins and contributes to the maintenance of hair, skin and nails.
Access the full article: Biolab Farmacêutica, Genéricos and Avert Saúde Humana present novelties during Conexão Farma 2026